[ Price : $8.95]
Public Citizen asks FDA to revise its planned research on the misuse of drugs and other substances to ensure that no funding goes ...[ Price : $8.95]
FDA alerts healthcare providers to not purchase or implant Synovos Total Hip System because modifications to the original device d...[ Price : $8.95]
Invivyd seeks FDA emergency use authorization for VYD222, which is described as a broadly neutralizing, half-life extended monoclo...[ Price : $8.95]
FDA approves Arcutis Biotherapeutics Zoryve topical foam to treat seborrheic dermatitis in individuals aged nine and older.[ Price : $8.95]
FDA issues a complete response letter for Zealand Pharmas dasiglucagon based on deficiencies at a third-party manufacturing facili...[ Price : $8.95]
FDA approves a label update for Kites Yescarta to include the overall survival primary analysis from the landmark Phase 3 Zuma-7 s...[ Price : $8.95]
FDA warns Singapores Wipro Unza Singapore Private, Limited, about refusing to respond to two agency records requests for informati...[ Price : $8.95]
FDA approves Ionis/AstraZenecas Wainua to treat adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis.